Skip to main content
. 2024 Dec 26;17(1):39. doi: 10.3390/cancers17010039

Table 1.

Antibodies used in the study.

Antibody M/P Clone Source Specificity Significance Dilution
ER M 1D5 DAKO Semiquantitative ER nuclear detection in BC +—≥1% 1:50
PR M PgR636 DAKO Semiquantitative PR nuclear detection in BC. +—≥20% 1:50
HER2 M 4B5 DAKO Membrane expression HER2 in BC +—>10% 1:500
Ki-67 M MIB-1 DAKO Nuclear protein that is associated with and may be necessary for cellular proliferation
Cellular marker for proliferation (Ki-67 Index)
Low—<14% 1:10
Moderate—<20%
High—>20%

Legend: BC = Breast cancer; ER = Estrogen Receptor; HER-2 = Receptor tyrosine kinase erbB-2; Ki-67 = Antigen Kiel 67; PR = Progesterone Receptor; M = Monoclonal; P = Polyclonal.